Theravance Biopharma Inc (TBPH)
Net Change in Cash
-$64.67M
Quarterly · Period ending: · USD
TBPH Net Change in Cash
Latest reported-$64.67Mperiod ending
Latest reported-$64.67Mperiod ending
TBPH Quarterly Net Change in Cash ($0.00 → -$64.67M)
Quarterly net change in cash
High-resolution chart · PNG
TBPH net change in cash history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Net Change in Cash (USD) |
|---|---|
| -64,674,000 | |
| 120,295,000 | |
| -6,967,000 | |
| -107,154,000 | |
| 171,313,000 | |
| 72,817,000 | |
| 14,419,000 | |
| -22,967,000 | |
| -7,490,000 | |
| 14,290,000 | |
| -32,140,000 | |
| -33,911,000 | |
| -82,069,000 | |
| -110,507,000 | |
| -120,366,000 | |
| 331,246,000 | |
| -7,075,000 | |
| 4,407,000 | |
| -31,461,000 | |
| -83,525,000 | |
| 90,938,000 | |
| 32,544,000 | |
| -11,815,000 | |
| -11,453,000 | |
| -228,063,000 | |
| 274,734,000 | |
| -51,835,000 | |
| -68,412,000 | |
| -44,924,000 | |
| -154,786,000 | |
| 276,819,000 | |
| -2,652,000 | |
| -21,977,000 | |
| 36,851,000 | |
| -2,321,000 | |
| -48,325,000 | |
| -30,319,000 | |
| -174,764,000 | |
| 258,137,000 | |
| -61,791,000 | |
| 19,560,000 | |
| 16,096,000 | |
| -14,407,000 | |
| 30,024,000 | |
| -3,809,000 | |
| 11,684,000 | |
| -33,013,000 | |
| -145,971,000 | |
| 324,098,000 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 |